Home Hpets

Hpets

In operation
-
Pet Innovative Drug Developer
Basic
Enterprise Profile

Basic Information

Hpets Biotech (Chongqing) Co.,ltd was founded in 2022. Based in Chongqing, the company focuses on developing first-in-class and best-in-class innovative pet medications, with its sights set both within China and internationally. Currently, Hpets has developed a range of innovative products targeting chronic diseases, gastrointestinal diseases, metabolic disorders, and next-generation antibiotics for pets.
Hpets Biotech (Chongqing) Co.,ltd
Chongqing,China
15~50 people
September 22, 2022
info@hanpets.com

Enterprise Profile

Industrial Sector
Nutritional Supplement Manufacturing Health Supplement Manufacturing New Drug Development Production of Pharmaceutical Intermediates
Concept
Infectious Diseases Digestive System Diseases Therapeutic Products
Application Scenarios
Innovative Drugs